LS

Life Sciences Research Partners V.Z.W.

Europe, Vlaams-Brabant, Belgium, Leuven

Description

Life Sciences Research Partners V.Z.W. engages in life sciences research and development.

Investor Profile

Life Sciences Research Partners V.Z.W. has made 3 investments, with 0 in the past 12 months and 0% as lead.

Stage Focus

  • Series D (33%)
  • Series A (33%)
  • Series B (33%)

Country Focus

  • Belgium (67%)
  • United States (33%)

Industry Focus

  • Biotechnology
  • Health Care
  • Health Diagnostics
  • Medical
  • Medical Device
  • Oncology
  • Therapeutics
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Life Sciences Research Partners V.Z.W. frequently co-invest with?

Grifols
Europe, Catalonia, Spain, Barcelona
Co-Investments: 1
NV
Europe, Brabant Wallon, Belgium, Mont-saint-guibert
Co-Investments: 1
Fund+
Europe, Vlaams-Brabant, Belgium, Leuven
Co-Investments: 1
HV
Europe, Luxembourg, Luxembourg, Luxembourg
Co-Investments: 2
S.R.I.W.
Europe, Liege, Belgium, Liège
Co-Investments: 1
SFPI-FPIM
Europe, Brussels Hoofdstedelijk Gewest, Belgium, Brussels
Co-Investments: 1
BA
Europe, Brabant Wallon, Belgium, Mont-saint-guibert
Co-Investments: 1

What are some of recent deals done by Life Sciences Research Partners V.Z.W.?

Bone Therapeutics

Gosselies, Hainaut, Belgium

Bone Therapeutics is a biopharmaceutical company developing cell therapy products for the treatment of osteo-articular diseases.

BiotechnologyHealth CareHealth Diagnostics
Series DJan 28, 2013
Amount Raised: $10,356,715
ITeos Therapeutics

Cambridge, Massachusetts, United States

ITeos Therapeutics is a biotechnology company that specializes in tumor immunology, cancer immunotherapy, and drug discovery.

BiotechnologyHealth CareMedical
Series AMay 3, 2012
Amount Raised: $11,830,415
Celyad

Mont-saint-guibert, Brabant Wallon, Belgium

Celyad is a provider of cell therapy treatments with an initial focus on cardiology and oncology.

BiotechnologyMedical DeviceOncologyTherapeutics
Series BJan 19, 2009
Amount Raised: $9,497,954